Trump’s Tariff Pause Creates Crypto Gold Rush [sponsor]
[adv]

Hedge fund Millennium valued at $14 billion in minority stake sale talks, FT reports
The company is working with Goldman Sachs’ Petershill Partners to identify potential buyers for a 10% to 15% equity stake in its management company, the report said. Millennium and Petershill did not immediately respond to Reuters’ requests for comment.Millennium manages over $75 billion across a range of ass … Read More >>

Weiss Gold Veteran Makes Shocking New Call [sponsor]
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold … and reveals a little-known way to get ahead of this bull market. Watch this time-sensitive gold bulletin now.

Lockheed, Boeing tout Golden Dome credentials at Paris air show
PARIS (Reuters) -Lockheed Martin and Boeing said on Monday they are positioning themselves to secure a significant share of U.S. President Donald Trump’s Golden Dome missile defense system, as competition intensifies over what could become one of the world’s largest defense contracts.Announced by Trump in Jan … Read More >>

The EXACT DAY Certain Stocks Soar – Year After Year [sponsor]
TradeSmith’s breakthrough system predicts the biggest jumps on 5,000 stocks – to the day – using a secret pioneered by the world’s greatest hedge fund. By running 50,000 daily tests across 33 years of stock market history, it finds which days of the year certain stocks have a history of soaring. Want to see when 5 of the best-known stocks in America could soar? Find out now – completely free of charge.

Lilly to offer highest doses of weight-loss drug Zepbound on website
With the addition of the 12.5 milligrams and 15 mg doses, all approved doses of Zepbound will be available on the website in single-dose vials for $499 per month or less, regardless of insurance status, the company said.Doctors can begin prescribing the higher-dose vials on July 7.Lilly and rival Novo Nordisk … Read More >>

Drink Coffee at Least once a Week? (Must See This) [sponsor]
There are two different types of coffee drinkers in this world.. One who likes to drink their coffee black, and one that likes to add a little cream. However, a very shocking discovery revealed that one of these people are much more prone to damaging their digestive lining and experiencing digestive issues. And even if you drink coffee just one day a week, you are going to want to see this shocking video.

US pharma bets big on China to snap up potential blockbuster drugs
(Reuters) -U.S. drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.Through June, U.S. drugmakers have signed 14 deals potentially worth … Read More >>

Sleep well at night with 7 stellar stocks to buy and hold forever [sponsor]
Every powerhouse name on this list is already a proven winner. You won’t find any risky moonshots, startups, or unicorns. Just best-in-class blue chips you can hold for years to come. Get the complete list FREE for a limited time.

Sponsored Content

Trump’s Tariffs = Your Payday [sponsor]

Nvidia could 10x, but THIS could 100x [Wall St Legend] [sponsor]

Trump signed Exec Order to “Make Americans Rich Again”? [sponsor]

Disclaimer: This is a paid advertisement for educational purposes only and does not constitute financial advice. Investing involves risk and may not be suitable for all individuals. Past performance does not guarantee future results.
Daily Gold Alerts is operated by ProTrading Research, LLC. We are not licensed financial advisors. Always consult with a certified financial professional before making investment decisions.

IMPORTANT NOTICE AND DISCLAIMER
ProTrading Research, LLC (“PTR”), the owner of this website (the “Website”), cannot guarantee the accuracy or completeness of the information contained in any article, email, newsletter, or other publication posted on or viewed in connection with this website (the “Publications”). The author or authors of those Publications are solely responsible for their contents. PTR has not done any research or due diligence into the markets, industries, or companies which may appear or be mentioned in the Publications. PTR will NOT be liable for any loss or damage caused by a reader’s reliance on information posted on the Website or contained in the Publications.

FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY; NOT INVESTMENT ADVICE.
This Website and the Publications are for educational and informational purposes only. This Website and the Publications do not purport to be a complete analysis of any company’s financial position. This Website, the Publications or any statements made in the Publications are not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. This Website or the statements made in the Publications should NOT be relied upon for purposes of transacting in any securities posted on the Website or mentioned in the Publications, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security posted on this Website or mentioned in any Publications.

SUBSTANTIAL RISK IN INVESTMENT.
Any individual who chooses to invest in any securities including those mentioned in the Publications should do so with caution. Investing or transacting in securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers bear responsibility for their own investment research and decisions and should review all investment decisions with a licensed or registered investment professional.

NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER
Neither PTR nor any of its respective owners or employees are registered or licensed as a securities broker-dealer, broker, an investment advisor, or an investment advisor representative with the U.S. Securities and Exchange Commision (SEC), any state securities regulatory authority, or any self-regulatory organization.

To view our full policies: Disclaimer | Privacy Policy | Terms & Conditions

Daily Gold Alerts
203 N La Salle Street, Suite 2100 | Chicago, IL 60601

unsubscribe

Breaking

Lockheed, Boeing tout Golden Dome credentials at Paris air show

Sponsored Content

You Missed

Lockheed, Boeing tout Golden Dome credentials at Paris air show

US pharma bets big on China to snap up potential blockbuster drugs

Lilly to offer highest doses of weight-loss drug Zepbound on website

Lockheed, Boeing tout Golden Dome credentials at Paris air show

Live Market Pulse

Recent Posts

Breaking

Lockheed, Boeing tout Golden Dome credentials at Paris air show

Sponsored Content

Related Posts

Crypto giants set for EU green light amid growing regulatory rift, sources say

Moderna falls on doubts over new CDC panel’s backing of RSV vaccine

Tesla robotaxi rollout in Austin tests Musk’s vision of self-driving future

You Missed

Lockheed, Boeing tout Golden Dome credentials at Paris air show

US pharma bets big on China to snap up potential blockbuster drugs

Lilly to offer highest doses of weight-loss drug Zepbound on website

Lockheed, Boeing tout Golden Dome credentials at Paris air show